“Global Biotech IP Update: Patent Eligibility Requirements in Life Sciences”
March 3-4, 2015 – PresentationDavid Gass, partner in Marshall, Gerstein & Borun LLP's biotech practice group, participated in a webinar titled “Global Biotech IP Update: Patent Eligibility Requirements in Life Sciences” with co-presenters Robert Dempster, UK and European patent attorney at Maschio & Soames IP Limited, and Karen Innes, senior associate and registered Australian and New Zealand Patent Attorney at FB Rice. During this webinar, panelists discussed recent developments in life sciences, and recent court decisions and practice changes, including the newest USPTO guidelines.